Diabetic ketoacidosis associated with olanzapine in an adolescent patient.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11391346.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Olanzapine (Zyprexa) is an atypical neuroleptic used in adult and pediatric patients for the management of schizophrenia. Common side effects include increased appetite and weight gain. An uncommon but severe adverse effect is the development of diabetic ketoacidosis, reported until now only in adults. We report a case of acute onset diabetic ketoacidosis presenting in a 16-year-old girl during olanzapine therapy.
Medical subject headings
- Antipsychotic Agents
- Diabetic Ketoacidosis
- Pirenzepine